Home
MedImmune, LLC

MedImmune, LLC Market Share Analysis for June 2026

astrazeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

Health > Biotechnology and Pharmaceuticals

Domainmedimmune.com

Year Founded1988

Employees1001 - 5000

Annual Revenue$200M - $500M

MedImmune, LLC

MedImmune, LLC (including company regionals)

medimmune.com

See more website traffic and engagement information

MedImmune, LLC Revenue up to June 2026 is 200M - 500M

revenue generated by MedImmune, LLC top domains

MedImmune, LLC top domains revenue over 3 years

Revenue for MedImmune, LLC top domains

medimmune.com200M - 500M

See more with Sales Intelligence

Total visits to MedImmune, LLC's top domains

Understand MedImmune, LLC market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in MedImmune, LLC's top domains

Analyze MedImmune, LLC engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on MedImmune, LLC's top domains

See how MedImmune, LLC keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

MedImmune, LLC top competitors by domain

Top similar sites in June 2026, ranked by their affinity

amgen.comCompany NameAmgenEmployees> 10001HQUnited States, California, Thousand OaksAnnual revenue> $1BTotal visits638.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by MedImmune, LLC

These are the website technologies, by industry, used by MedImmune, LLC top domains

Social (5)

Instagram

Audio Video Media (4)

YouTube

Conversion & Analytics (3)

Google Analytics

Marketing (2)

Google Marketing Platform

More Technologies

6

See all

News & Signals from MedImmune, LLC

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAstraZeneca group acquired Medimmune for $15.6B on Jan 1st '07.It's located just a few miles away from the major research and development center in Gaithersburg, Maryland, that AstraZeneca acquired through its $15.6 billion purchase of MedImmune in 2007.

NewsAstraZeneca UK Ltd. acquired Medimmune on Jan 1st '07.AstraZeneca added the facility in Liverpool, UK through its acquisition of MedImmune in 2007.

NewsSanofi partnered with Medimmune on Jan 1st '17.For instance, in 2017, Sanofi S.A. and its vaccines business unit Sanofi Pasteur collaborated with MedImmune, the global biologics research and development arm of AstraZeneca Plc., for the development and commercialization of a monoclonal antibody, namely MEDI8897, for the prevention of Respiratory Syncytial Virus (RSV) associated illness in newborns and infants.